Emzor Pharmaceutical Industries Competitors and Similar CompaniesClear all

Emzor Pharmaceutical Industries's competitors and similar companies include Australasian Medical & Scientific, Weiguang Biological, Tiansheng Pharmaceutical and Demo Pharmaceuticals.

	Emzor Pharmaceutical Industries Emzor Pharmaceutical Industries is a company that manufactures and distributes pharmaceutical products and medical consumables.	Australasian Medical & Scientific Australasian Medical & Scientific is a provider of medical devices and medicines.	Weiguang Biological Weiguang Biological is a company that manufactures blood products.	Tiansheng Pharmaceutical Tiansheng Pharmaceutical is a company that manufactures pharmaceutical products.	Demo Pharmaceuticals DEMO is a manufacturer and supplier of pharmaceutical products.
Founding Date	Founding Date 1984	Founding Date 1991	Founding Date 1985	Founding Date 2001	Founding Date N/A
Type	Type Subsidiary	Type Private	Type Public	Type Public	Type Private
Tags	Tags Manufacturing & Industrial pharma surgical solutions	Tags Manufacturing & Industrial medical devices medical diagnostics medical imaging pharma surgical solutions	Tags Manufacturing & Industrial pharma	Tags Manufacturing & Industrial pharma	Tags Manufacturing & Industrial pharma
Locations	Locations Lagos, NG HQ Monrovia, LR Awka, NG Ikeja, NG Lagos, NG Lagos, NG Lagos, NG see more	Locations Sydney, AU HQ	Locations Shenzhen, CN HQ	Locations Chongqing, CN HQ	Locations Athens, US HQ Hallbergmoos, DE Krioneri, GR Thessaloniki, GR
Employees	Employees 1,1711% increase	Employees 62	Employees 859	Employees 1,272	Employees 9641% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 887.6 m	Valuation ($) 197.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥1.2b (FY, 2025)	Revenue (est.) ¥515.7m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥768.1m (FY, 2025)	Cost of goods ¥298.2m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥487.7m (FY, 2025)	Gross profit ¥258.3m (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ¥245.8m (FY, 2025)	Net income (¥88.1m) (FY, 2024)	Net income N/A